Furthermore, AESS serum reduced the expression of the p-IκB-α and p-NF-κB p65 proteins, indicating that AESS inhibits the activity of the NF-κB signaling pathway in the AD-like cell model (Figure 5H and Supplemental Figure S1C). Here, NFKB1 is linked to Alzheimer disease.